Comoros vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Comoros
100.0%
in 2023
Oman
100.0%
in 2024
Comoros rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Comoros
- Oman
How they compare
Comoros currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 5 times across 11 shared years of data; in 2005 it was Oman ahead.
Comoros ranks 1st and Oman ranks 1st of 144 countries.
Comoros has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Comoros | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 91.3% | 8.7% | Comoros |
| 2020s | 91.8% | 89.2% | 2.5% | Comoros |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Comoros or Oman?
- Comoros, at 100.0% against 100.0% in Oman as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Comoros and Oman?
- 0.0%, with Comoros ahead.
- How many years of comparable data are there for Comoros and Oman?
- 11 years are reported by both, from 2005 to 2023.
- How do Comoros and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Comoros ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.